Evolent Health
EVH
$30.13
Share price
0.90%
Change (1 day)
-14.79%
Change (1 year)
Categories
Evolent Health (EVH) - P/B ratio
P/B ratio as of April 2024 : 3.21
According to Evolent Health's latest financial reports the company has a price-to-book ratio of 3.21.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Evolent Health - P/B ratio (from 2015 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.56 | 7.56% |
| 2022-12-31 | 3.31 | -7.3% |
| 2021-12-31 | 3.57 | 63.43% |
| 2020-12-31 | 2.18 | 164.86% |
| 2019-12-31 | 0.8240 | -37.95% |
| 2018-12-31 | 1.33 | 51.26% |
| 2017-12-31 | 0.8780 | 2.91% |
| 2016-12-31 | 0.8531 | 58.68% |
| 2015-12-31 | 0.5376 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 National Healthcare
NHC | 1.54 | -52.03% | 🇺🇸 USA |
 Global Cord Blood CORBF | 0.2349 | -92.69% | 🇭🇰 Hong Kong |
 Graham Holdings GHC | 0.8007 | -75.09% | 🇺🇸 USA |